Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 817 of 6351
-
A stronger core, a lighter back? exercise trial targets chronic pain in older adults
Symptom relief CompletedObjectives: To develop an exercise program for older adults with low back pain. And,to develop a clinical prediction rule that could identify a subgroup of people with NSLBP Participants: 150 people aged between 40 to 80 with non-specific low back pain (NSLBP) for more than 6 m…
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Ovarian cancer combo shows promise in maintenance therapy
Disease control OngoingThe goal of this prospective, phase IV, multi-centre clinical trial is to to define the proportion of patients with advanced high grade epithelial ovarian cancer (EOC) HRD-positive who will be treated at first line with olaparib in combination with bevacizumab as maintenance and …
Phase 4 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New bladder cancer therapy shows promise in early trial
Disease control Recruiting nowTARA-002-101-Ph2 is an open-label study to investigate the safety and efficacy of intravesical instillation of TARA-002 in adults 18 years of age or older with high-grade CIS NMIBC (± Ta/T1). The purpose of this Phase 2 study (TARA-002-101-Ph2) is to further assess the safety an…
Phase 2 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Cutting radiation in CT scans: a new test of Ultra-Low-Dose imaging
Diagnosis CompletedThe new image reconstruction algorithm (Precise Image, Philips Healthcare) has a strong potential to maintain sufficient image quality suitable for diagnosis with ultra-low dose (ULD) chest and abdomen-pelvis scans. The hypothesis is that the images obtained with the Precise Ima…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
Weekly shot helps people shed pounds in Year-Long study
Disease control CompletedThis study will look at how the investigational dose of semaglutide works in helping people with excess body weight, to lose weight. This study will compare the weight loss in people taking semaglutide to people taking "dummy" medicine (placebo). The study will last for about 1 y…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug could ease endometriosis pain in major trial
Symptom relief CompletedThis is a phase 3, multicenter, double-blind, placebo-controlled, randomized study to evaluate the efficacy and safety of elagolix tablets versus placebo in premenopausal women with moderate or severe endometriosis-associated pain.
Phase 3 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New drug combo aims to beat back leukemia relapse after transplant
Disease control Recruiting nowRelapse remains the main cause of death in patients with myeloid malignancies, especially after an allotransplant. Using drugs with higher anti-leukemic activity as part of the conditioning regimen is one of the strategies to decrease relapse incidence in this population. Retrosp…
Phase 2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for lung scarring: experimental drug enters final testing phase
Disease control OngoingThe purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in participants with Idiopathic Pulmonary Fibrosis.
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Engineered immune cells take on lupus and other autoimmune diseases
Disease control OngoingThe purpose of this study is to establish the tolerability, preliminary efficacy, and pharmacokinetics of CC-97540 in participants with severe, refractory autoimmune diseases (Breakfree-1).
Phase 1 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a lupus drug help scleroderma lungs?
Disease control Recruiting nowThis study investigates the efficacy and safety of belimumab compared to placebo, in addition to standard therapy, for the treatment of participants with systemic sclerosis associated interstitial lung disease (SSc-ILD). The study will evaluate the effect of belimumab treatment o…
Phase 2/3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New pacing technique could help heart failure patients live longer
Disease control Recruiting nowThe investigators aim to prospectively test the comparative effectiveness of His or Left bundle branch pacing in relation to patient centered outcomes (quality of life, physical activity, heart failure hospitalization, mortality) and comparative safety in relation to device-relat…
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Fake-Fast diet may boost prostate cancer therapy
Disease control Recruiting nowThis is a Phase 2, randomized two-armed, multi-site study of 138 patients with metastatic castrate sensitive prostate adenocarcinoma. Patients will be randomized 1:1 to receive the fasting mimicking diet, or usual diet. All patients will receive standard of care treatment for the…
Phase 2 • Sponsor: Stephen Freedland • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Propofol vs. inhaled anesthesia: which one spares your recovery?
Knowledge-focused Recruiting nowThe investigators will conduct a 13,000-patient randomized multi-center trial to determine (i) which general anesthesia technique yields superior patient recovery experiences in any of three surgical categories ((a) major inpatient surgery, (b) minor inpatient surgery, (c) outpat…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Simple blood test may replace spinal taps for Alzheimer's diagnosis
Knowledge-focused Recruiting nowBLAD is a prospective, monocentric, observational epidemiological study with an additional procedure (annual blood draw) evaluating the diagnostic and prognostic performance of plasma biomarkers for Alzheimer's disease (AD) in a large cohort of patients attending the Cognitive Di…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
New hope for glioblastoma? drug combo trial launches
Disease control OngoingThis is a phase 2 study to evaluate the safety and preliminary evidence of effectiveness of azeliragon, in combination with radiation therapy, as an initial treatment of a form of glioblastoma. Glioblastoma is a type of brain cancer that grows quickly and can invade and destroy h…
Phase 2 • Sponsor: Cantex Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug shows promise for regrowing hair in severe alopecia
Disease control OngoingPart A is a randomized, double-blind, placebo-controlled, multi-center Proof-of-Concept (POC) Trial in subjects with severe Alopecia Areata. All participants in Part A have completed participation. Part B is a multicenter, open-label study to assess the efficacy, safety, and tol…
Phase 2 • Sponsor: Q32 Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Simple blood test could predict Alzheimer's brain changes years before symptoms
Diagnosis OngoingThe primary purpose of this study is to identify participants with or without symptoms of Alzheimer's Disease (AD) that are at high risk for brain amyloid pathology using blood-based biomarkers.
Sponsor: Eisai Limited • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Tailored transplant doses aim to beat blood cancer
Disease control Recruiting nowThis is a prospective, single-arm, phase II study. Patients will be treated with an allogeneic stem cell transplantation (AHSCT) using fludarabine, melphalan and total body irradiation (TBI) conditioning with different melphalan and TBI doses based on patient- and disease-related…
Phase 2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New pill could tame Sjögren's syndrome
Disease control OngoingThe purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a common antibiotic help fight colorectal cancer?
Disease control Recruiting nowThe proposed proof-of concept trial aims at determining the effectiveness of metronidazole in decreasing the Fusobacterium nucleatum load in tissues and possibly on its detrimental effects on tumor cells and tumor microenvironment.
Phase 2 • Sponsor: Oncology Institute of Southern Switzerland • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC